NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
"Bortezomib" is the Drug / Molecule content in "Bortenat". Bortezomib is a reversible inhibitor of the chymotrypsin-like activity of proteasome. It prevents targeted proteolysis that affects multiple signaling cascades responsible for normal homeostatic functions within the cell, leading to cell death.
Indication
Bortenat is used for the treatment of Multiple Myeloma. Also used for Mantle Cell Lymphoma
Note
Precaution
- Bortenat is a prescription drug and should be used under proper medical guidance and advice.
- Contraindicated in in patients with hypersensitivity to Bortezomib, boron or mannitol.
Updated On Oct 15, 2019 by Admin
Strength
2 mg & 3.5 mg
Packing
Vial
Storage
Store below 25°C, excursions permitted upto 30°C and protect from light and moisture
Was this page helpful?
Related Products
NATCO PHARMA LIMITED. (INDIA)
Bortenat
CELGENE
Revlimid-lenalid
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)